Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ZEST II for Osteoporotic Fracture Prevention

NCT02589600 is registered in ClinicalTrials.gov with Susan L. Greenspan as lead sponsor.

NCT NCT02589600
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02589600 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ZEST II for Osteoporotic Fracture Prevention
Lead sponsor
Susan L. Greenspan
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2016
Completion date
June 22, 2022
Enrollment
310 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

osteoporosis, postmenopausal, osteoporotic fractures